ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382049; 2) Community: the network communities that were significantly associated with the response to NSC 382049; 3) Molecule: the relationships between components within communities and NSC 382049; 4) MDR: the compounds that were significantly associated with the NSC 382049.

NSC Compound Enrichment Correlation
NSC 691608 Null 0.0244632509325736 0.18813182
NSC 693635 Null 0.0244632509325736 0.33879826
NSC 694000 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester 0.0244632509325736 0.21623048
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0244632509325736 0.33478558
NSC 697886 17-Demethoxy-17-allylamino geldanamycin-11-[4-(dimethylamino)butyrate] 0.0244632509325736 0.31563827
NSC 699680 Z-.alpha.-Chlorochalcone 0.0244632509325736 0.33610233
NSC 702158 7-epi-3,4-bis-nor-dolastatin 11 0.0244632509325736 0.2984302
NSC 702322 Null 0.0244632509325736 0.14235805
NSC 706995 Entinostat 0.0244632509325736 0.020816739
NSC 715584 Null 0.0244632509325736 0.30762503
Total:136  Current:85    [First] [Prev] [Next] [Last]